Page last updated: 2024-10-18

dalteparin and Complications of Diabetes Mellitus

dalteparin has been researched along with Complications of Diabetes Mellitus in 7 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"In the ACUITY trial, 13,819 patients with moderate- or high-risk acute coronary syndromes (ACS) were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa inhibition (GPI), bivalirudin plus GPI, or bivalirudin monotherapy."9.13Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. ( Attubato, MJ; Ebrahimi, R; Feit, F; Manoukian, SV; Mehran, R; Ohman, EM; Pollack, CV; Stone, GW, 2008)
"In the ACUITY trial, 13,819 patients with moderate- or high-risk acute coronary syndromes (ACS) were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa inhibition (GPI), bivalirudin plus GPI, or bivalirudin monotherapy."5.13Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. ( Attubato, MJ; Ebrahimi, R; Feit, F; Manoukian, SV; Mehran, R; Ohman, EM; Pollack, CV; Stone, GW, 2008)
"Diabetes mellitus is a major contributor to CAD."2.71Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. ( Diderholm, E; Lagerqvist, B; Lindahl, B; Malmberg, K; Norhammar, A; Rydén, L; Wallentin, L, 2004)
" Recently, the use of safe-dose recombinant tissue-type plasminogen activator (rTPA) has been proposed for the treatment of moderate PE demonstrating to be safe and more effective than standard anticoagulation."2.50[Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature]. ( Cannone, M; La Torre, PP; Mele, A; Mele, M, 2014)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ng, QX1
Seng, C1
Ho, CYX1
Yeo, WS1
Mele, M1
Mele, A1
La Torre, PP1
Cannone, M1
Carballo, S1
Carballo, D1
Keller, PF1
Roffi, M1
Morrow, DA1
Antman, EM1
Murphy, SA1
Qin, J1
Ruda, M1
Guneri, S1
Jacob, AJ1
Budaj, A1
Braunwald, E1
Feit, F1
Manoukian, SV1
Ebrahimi, R1
Pollack, CV1
Ohman, EM1
Attubato, MJ1
Mehran, R1
Stone, GW1
Skeppholm, M1
Kallner, A1
Kalani, M1
Jörneskog, G1
Blombäck, M1
Wallén, HN1
Norhammar, A1
Malmberg, K1
Diderholm, E1
Lagerqvist, B1
Lindahl, B1
Rydén, L1
Wallentin, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prevalence of the Appearance of Diabetic Ulcers, After the Manufacture and Adaptation of Personalized Insoles, With Monitoring of Temperature and Plantar Pressure in Diabetic Patients[NCT05843929]86 participants (Anticipated)Interventional2024-02-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for dalteparin and Complications of Diabetes Mellitus

ArticleYear
[Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
    Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:4

    Topics: Aged, 80 and over; Anemia, Hypochromic; Anticoagulants; Bundle-Branch Block; Diabetes Complications;

2014

Trials

3 trials available for dalteparin and Complications of Diabetes Mellitus

ArticleYear
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRAC
    American heart journal, 2007, Volume: 154, Issue:6

    Topics: Aged; Aspirin; Diabetes Complications; Drug Therapy, Combination; Electrocardiography; Enoxaparin; F

2007
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    Journal of the American College of Cardiology, 2008, Apr-29, Volume: 51, Issue:17

    Topics: Acute Coronary Syndrome; Acute Disease; Adult; Aged; Aged, 80 and over; Anticoagulants; Cardiac Cath

2008
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Journal of the American College of Cardiology, 2004, Feb-18, Volume: 43, Issue:4

    Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Dalteparin; Diabetes Co

2004

Other Studies

3 other studies available for dalteparin and Complications of Diabetes Mellitus

ArticleYear
Enoxaparin: A cause of postoperative fever?
    Medical hypotheses, 2018, Volume: 121

    Topics: Aged; Animals; Anticoagulants; Arthroplasty, Replacement, Knee; Cattle; Diabetes Complications; Enox

2018
[Specificities of diabetes in acute coronary syndromes].
    Revue medicale suisse, 2011, Jun-01, Volume: 7, Issue:297

    Topics: Acute Coronary Syndrome; Algorithms; Angioplasty; Anti-Inflammatory Agents, Non-Steroidal; Clopidogr

2011
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:8

    Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Case-C

2009
chemdatabank.com